Clinical study of oral propranolol treatment for infantile hemangiomas

Clinical study of oral propranolol treatment for infantile hemangiomas - Propranolol for infantile hemangiomas

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004604

Enrollment

Registered

2010-11-23

Start date

2010-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infantile hemangiomas

Interventions

oral propranolol

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: proliferating infantile hemangiomas

Exclusion criteria

Exclusion criteria: cardiac disease, asthma, disorder of carbohydrate metabolism

Design outcomes

Primary

Measure	Time frame
Change in size and color of infantile hemangiomas; presence or absence of complications	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026